These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312 [TBL] [Abstract][Full Text] [Related]
29. Identification by RNA-Seq of let-7 clusters as prenatal biomarkers for nonsyndromic cleft lip with palate. Jia S; Zhang Q; Wang Y; Wei X; Gu H; Liu D; Ma W; He Y; Luo W; Yuan Z Ann N Y Acad Sci; 2022 Oct; 1516(1):234-246. PubMed ID: 35854669 [TBL] [Abstract][Full Text] [Related]
30. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini MG; Padovani A; Di Luca M Neurobiol Aging; 2009 Jan; 30(1):34-40. PubMed ID: 17709155 [TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways. Jang Y; Thuraisamy T; Redding-Ochoa J; Pletnikova O; Troncoso JC; Rosenthal LS; Dawson TM; Pantelyat AY; Na CH Clin Transl Med; 2022 Nov; 12(11):e1076. PubMed ID: 36354133 [TBL] [Abstract][Full Text] [Related]
33. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes. Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454 [TBL] [Abstract][Full Text] [Related]
34. Positive regulation of innate immune response by miRNA-let-7a-5p. Ueta M; Nishigaki H; Komai S; Mizushima K; Tamagawa-Mineoka R; Naito Y; Katoh N; Sotozono C; Kinoshita S Front Genet; 2022; 13():1025539. PubMed ID: 36685889 [No Abstract] [Full Text] [Related]
35. Progressive supranuclear palsy: Advances in diagnosis and management. Coughlin DG; Litvan I Parkinsonism Relat Disord; 2020 Apr; 73():105-116. PubMed ID: 32487421 [TBL] [Abstract][Full Text] [Related]
36. Peripheral whole blood microRNA alterations in major depression and bipolar disorder. Maffioletti E; Cattaneo A; Rosso G; Maina G; Maj C; Gennarelli M; Tardito D; Bocchio-Chiavetto L J Affect Disord; 2016 Aug; 200():250-8. PubMed ID: 27152760 [TBL] [Abstract][Full Text] [Related]
37. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142 [TBL] [Abstract][Full Text] [Related]
38. Sequence analysis of tau in familial and sporadic progressive supranuclear palsy. Morris HR; Katzenschlager R; Janssen JC; Brown JM; Ozansoy M; Quinn N; Revesz T; Rossor MN; Daniel SE; Wood NW; Lees AJ J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):388-90. PubMed ID: 11861703 [TBL] [Abstract][Full Text] [Related]
39. A network approach to diagnostic biomarkers in progressive supranuclear palsy. Santiago JA; Potashkin JA Mov Disord; 2014 Apr; 29(4):550-5. PubMed ID: 24347522 [TBL] [Abstract][Full Text] [Related]
40. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]